UPDATE: UBS Downgrades Teva Pharma (TEVA) to Neutral
Tweet Send to a Friend
(Updated - May 4, 2021 4:21 AM EDT)
UBS analyst Kevin Caliendo downgraded Teva Pharma (NYSE: TEVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Kevin Caliendo downgraded Teva Pharma (NYSE: TEVA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
